FFRct vs IM007
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (FFRct) is a diagnostic tool that uses AI to analyze CCTA scans for coronary artery disease, aiding in initial diagnosis and treatment planning. Tool B (IM007) is a remote monitoring platform leveraging AI to manage data from cardiac implantable electronic devices, focusing on workflow efficiency and patient outcomes for existing conditions. While both are cardiology AI solutions, their distinct focus on diagnosis versus ongoing remote patient management makes them adjacent rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool that creates personalized 3D models of coronary arteries from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease. IM007 is an FDA-cleared, AI-powered, cloud-based platform for remote cardiac monitoring, aggregating data from all cardiac implantable electronic devices (CIEDs) to streamline workflows, reduce false alerts, and improve patient outcomes in cardiology and heart failure management.
FFRct analyzes anatomical and physiological data derived from CCTA scans to generate personalized 3D digital models of coronary arteries and assess blood flow. IM007 aggregates and analyzes data from various cardiac implantable electronic devices (CIEDs) from manufacturers like Abbott, Biotronik, Boston Scientific, Medtronic, and MicroPort.
FFRct utilizes AI and computational fluid dynamics to analyze CCTA data, providing FFRct values that aid in diagnosing coronary artery disease and guiding treatment strategies. IM007 employs AI for alert management, significantly reducing false positives from CIEDs (e.g., 79% for ILR ECG Analyzer, 85% for AF alerts), and includes predictive AI like SignalHF for heart failure hospitalization risk.
FFRct is designed for patients undergoing CCTA scans to assess and diagnose coronary artery disease. IM007 is intended for patients with cardiac implantable electronic devices (CIEDs) to facilitate remote monitoring and management, including those with heart failure.